Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2009 May;15(4):368-73.
doi: 10.1016/j.cardfail.2008.11.009. Epub 2008 Dec 18.

Decreased immune responses to influenza vaccination in patients with heart failure

Orly Vardeny  1 , Nancy K Sweitzer, Michelle A Detry, John M Moran, Maryl R Johnson, Mary S Hayney
Affiliations
Comparative Study

Decreased immune responses to influenza vaccination in patients with heart failure

Orly Vardeny et al. J Card Fail. 2009 May.

Abstract

Background: Heart failure (HF) patients are at risk for influenza despite widespread vaccination. Both humoral (antibody) and cytotoxic T-lymphocyte (CTL) responses are important for protection. We explored antibody- and CTL-mediated responses to the influenza vaccine in HF patients compared with healthy controls.

Methods and results: We studied 29 HF patients (9 ischemic, 20 nonischemic) stable on HF therapies and 17 healthy controls. Participants had phlebotomy before and after influenza vaccination. Antibody production was measured in serum by hemagglutination inhibition assay and CTL responses (via interferon [IFN]-gamma and interleukin [IL]-10 production) were measured in isolated peripheral blood mononuclear cells with enzyme-linked immunosorbent assay. CTL responses demonstrated increased IL-10 production in HF patients after vaccination (P = .002), but similar IFN-gamma responses to healthy controls. All participants demonstrated antibody seroprotection; groups had similar rates of seroconversion (P = NS). Antibody-mediated response to the newest vaccine antigen, H3N2, was reduced in HF (P = .009).

Conclusions: Patients with HF had higher vaccine induced IL-10 concentrations, suggesting a different CTL phenotype for vaccine responses. HF patients did not mount as vigorous of an antibody immune response to the newest vaccine viral strain compared with healthy individuals. These data suggest that immunologic memory may be important for vaccine protection in HF patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Absolute changes in IFNgamma and IL-10 production between HF and healthy controls. Values expressed as distribution of differences (pre and post vaccination) of log transformed IFNgamma and IL-10 concentrations. P=0.133, 0.002 for comparison between groups, respectively.
Figure 2
Figure 2
Absolute changes in influenza vaccine-mediated A/H3N2, A/H1N1, and B-Malaysia antibody productions (hemagglutination units) between HF and healthy controls. Values expressed as medians (box plot lines) of differences (pre and post vaccination) of log transformed serum antibody concentrations. P=0.009, 0.9, and 0.08, respectively, for comparison between groups. HF = heart failure, HC = healthy controls, HAU = hemagglutination units.
Figure 3
Figure 3
Absolute changes in influenza vaccine-mediated A/H3N2 antibody productions (hemagglutination units) within the HF group between participants on carvedilol versus metoprolol succinate. Values expressed as medians (box plot lines) of differences (pre and post vaccination) of log transformed serum antibody concentrations. P=0.06, for comparison between beta blocker groups. HAU = hemagglutination units.
See this image and copyright information in PMC

Comment in

References

    1. Fleming DM, Elliot AJ. The impact of influenza on the health and health care utilisation of elderly people. Vaccine. 2005 Jul 8;23( Suppl 1):S1–9. - PubMed
    1. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. The New England journal of medicine. 2003 Apr 3;348(14):1322–32. - PubMed
    1. Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International journal of epidemiology. 1995 Dec;24(6):1240–8. - PubMed
    1. Ahmed AH, Nicholson KG, Nguyen-van Tam JS, Pearson JC. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemic. Epidemiology and infection. 1997 Feb;118(1):27–33. - PMC - PubMed
    1. Hak E, Buskens E, van Essen GA, de Bakker DH, Grobbee DE, Tacken MA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Archives of internal medicine. 2005 Feb 14;165(3):274–80. - PubMed

Publication types

MeSH terms